Our understanding of adipocytic tumors classification and diagnosis continues to evolve. We present a brief review and updated summary of selected adipocytic tumors involving the head and neck region. For the practicing pathologist, knowledge of these established and emerging entities is critical for the correct pathologic diagnosis and treatment of the patient.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Enzinger FM, Harvey DA. Spindle cell lipoma. Cancer. 1975;36:781–8.
Shmookler BM, Enzinger FM. Pleomorphic lipoma: a benign tumor simulating liposarcoma. A clinicopathologic analysis of 48 cases. Cancer. 1981;47(1):126–33.
Goldblum JR, Folpe AL, Weiss SW, Enzinger FM. Weiss’s soft tissue tumors. Philadelphia: Mosby; 2014. p. 703–32.
Billings SD, Henley JD, Summerlin DJ, et al. Spindle cell lipoma of the oral cavity. Am J Dermatopathol. 2006;28:28–31.
Lau SK, Bishop JA, Thompson LD. Spindle cell lipoma of the tongue: a clinicopathologic study of 8 cases and review of the literature. Head Neck Pathol. 2015;9(2):253–9.
Cheah A, Billings SD, Goldblum JR, et al. Spindle cell/pleomorphic lipomas of the face: an under-recognized diagnosis. Histopathology. 2015;66:430–7.
Fanburg-Smith JC, Devaney KO, Miettinen M, et al. Multiple spindle cell lipomas: a report of 7 familial and 11 nonfamilial cases. Am J Surg Pathol. 1998;22:40–8.
Billings SD, Folpe AL. Diagnostically challenging spindle cell lipomas: a report of 34 “low-fat” and “fat-free” variants. Am J Dermatopathol. 2007;29(5):437–42.
Mandahl N, Hoglund M, Mertens F, et al. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosom Cancer. 1994;9:207–15.
Dal Cin P, Sciot R, Polito P, et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology. 2013;31:222–5.
Maggiani F, Debiec-Rychter M, Vanbockrijck M, et al. Celluar angiofibroma: another mesenchymal tumour with 13q14 involvement, suggesting a link with spindle cell lipoma and (extra)-mammary myofibroblatoma. Histopathology. 2007;51:410–2.
Pauwels P, Sciot R, Croiset F, et al. Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol. 2000;191:282–5.
Agaimy A, Michal M, Giedl J, et al. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/deletions. Hum Pathol. 2017;60:192–8.
Chen BJ, Marino-Enriquez A, Fletcher CD, et al. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumros: an immunohistochemical study with diagnostic implications. Am J Surg Pathol. 2012;36:1119–28.
Gerry D, Fox NF, Spruill LS, et al. Liposarcoma of the head and neck: analysis of 318 cases with comparison to non-head and neck sites. Head Neck. 2014;36:393–400.
Gritli S, Khamassi K, Lachkhem A, et al. Head and neck liposarcomas: a 32 years experience. Auris Nasus Larynx. 2010;37:347–51.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013) World Health Organization Classification of Tumours of Soft Tissue and Bone
Waters R, Horvai A, Greipp P, et al. Atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma in patients aged ≤ 40 years: a study of 116 patients. Histopathology. 2019;75(6):833–42.
Henrick WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271–81.
Dickson MA, Tap WD, Keohan ML, et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. J Clin Oncol. 2013;31:2024–8.
Constantinidou A, Pollack SM, Jones RL. MDM2 inhibition in liposarcoma: a step in the right direction. Lancet Oncol. 2012;13:1070–1.
Agaimy A, Michal M, Hadravsky L, et al. Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithleioid cells: a frequently misdiagnosed highly aggressive variant. Hum Pathol. 2018;77:20–7.
Evans HL, Khurana KK, Kemp BL, et al. Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma. Am J Surg Pathol. 1994;18:1150–7.
Fanburg-Smith JC, Miettinen M. Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma. Histopathology. 1998;33:141–424.
Nascimento AG, Kurtin PJ, Guillou L, et al. Dedifferentiated liposarcoma: a report of nine cases with a peculiar neurallike whorling pattern asscoaited with metaplastic bone formation. Am J Surg Pathol. 1998;22:945–55.
Boland JM, Weiss SW, Oliveira AM, et al. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2010;34:837–43.
Marino-Enriquez A, Fletcher CD, Dal Cin P, et al. Dedifferentiated liposarcoma with “homologous” lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and moelcular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol. 2010;34:1122–31.
Ng W, Messiou C, Smith M, et al. p16 expression in fat necrosis: a potential diagnostic pitfall in the evaluation of differentiated adipocytic neoplasms. Int J Surg Pathol. 2015;23:544–8.
Stojanov IJ, Marino-Enriquez A, Bahri N, et al. Lipomas of the oral cavity: utility of MDM2 and CDK4 in avoiding overdiagnosis as atypical lipomatous tumor. Head Neck Pathol. 2019;13:169–76.
Doyle LA, Tao D, Marino-Enriquez A. STAT6 is amplified in a subset of dedifferentiated liposarcoma. Mod Pathol. 2014;27:1231–7.
Ratan R, Patel SR. Trabectedin and eribulin: where do they fit in the management of soft tissue sarcoma? Curr Treat Options Oncol. 2017;18:34.
Iwasaki H, Ishiguro M, Nishio J, et al. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses. Virchows Arch. 2015;466:453–64.
Dadone B, Refae S, Lemarie-Delaunay C, et al. Molecular cytogenetics of pediatric adipocytic tumors. Cancer Genet. 2015;208:469–81.
Pedeutour F, Deville A, Steyaert H, et al. Rearrangement of HMGA2 in a case of infantile lipoblastoma without Plag1 alteration. Pediatr Blood Cancer. 2012;58:798–800.
Gardner JM, Dandekar M, Thomas D, et al. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26. Am J Surg Pathol. 2012;36:1047–51.
Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26:601–16.
Hornick JL, Bosenberg MW, Mentzel T, et al. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257–67.
Miettinen M, Enzinger FM. Epithelioid variant of pleomorphic liposarcoma: a study of 12 cases of a distinctive variant of high-grade liposarcoma. Mod Pathol. 1999;12:722–8.
Barretina J, Taylor BS, Banerji S, et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet. 2010;42:715–21.
Cancer Genome Atlas Research Network. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell. 2017;171(4):950.
Evans HL (2015) Subcutaneous minimally atypical lipomatous tumors with variable fat cell size—a study of 13 cases. Mod Pathol 28 (suppl 2_:17A
Evans HL. Anisometric cell lipoma: a predominantly subcutaneous fatty tumor with notable variation in fat cell size but not more than slight nuclear enlargement and atypia. AJSP. 2016;21(4):195–9.
Michal M, Agaimy A, Contreras AL, et al. Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH: a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol. 2018;42:1530–40.
Marino-Enriquez A, Nascimento AF, Ligon AH, et al. Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum. Am J Surg Pathol. 2017;41:234–44.
Creytens D, Mentzel T, Ferdinande L, et al. “Atypical” pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical and molecular study of 21 cases, emphasizing its relationship to atypical spindle cell lipomatous tumor and suggesting a morphologic spectrum (atypical spindle cell/pleomorphic lipomatous tumor). Am J Surg Pathol. 2017;41:1443–55.
Bahadir B, Behzatoglu K, Hacihasanoglu E, et al. Atypical spindle cell/pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical, and molecular study of 20 cases. Pathol Int. 2018;68:550–6.
Italiano A, Chambonniere ML, Attias R, et al. Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcoma. Cancer Genet Cytogenet. 2008;184:99–104.
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shon, W., Billings, S.D. Soft Tissue Special Issue: Selected Topics in the Pathology of Adipocytic Tumors. Head and Neck Pathol (2020) doi:10.1007/s12105-019-01112-3
- Spindle cell lipoma
- Pleomorphic lipoma
- Anisometric cell lipoma
- Dysplastic lipoma
- Atypical spindle cell lipomatous tumor